Figure 2From: Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibitionRelationship of PIK3CA mutation status with biomarkers and molecular subtype. (A) Oestrogen receptor (ER) (n = 83). (B) Progesterone receptor (PgR) (n = 83). Data are shown with medians and IQRs. Mu, Mutant; WT, Wild type.Back to article page